The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary Study
Jin-Hyoung Kim, Hae-Won Seo, Hyun-Cheol Han, Jong-Hyun Lee, Suk-Kyue Choi, Doh Lee
Korean J Ophthalmol. 2013;27(4):235-242.   Published online 2013 Jul 5     DOI: https://doi.org/10.3341/kjo.2013.27.4.235
Citations to this article as recorded by Crossref logo
A Charge Variant of Bevacizumab Offers Enhanced FcRn-Dependent Pharmacokinetic Half-Life and Efficacy
Sumit K. Singh, Deepak Kumar, Saurabh Nagpal, Sunil K. Dubey, Anurag S. Rathore
Pharmaceutical Research.2022; 39(5): 851.     CrossRef
A Case of Iris Neovascularization in Severe Fungal Keratitis Treated with Intracameral Bevacizumab
Yeon Ju Lim, Chan-Ho Cho
Journal of the Korean Ophthalmological Society.2022; 63(5): 472.     CrossRef
Twenty years since the Herpetic Eye Disease Study: Lessons, developments and applications to clinical practice
Sana Arshad, Constantinos Petsoglou, Taehwan Lee, Abdullah Al-Tamimi, Nicole A. Carnt
Clinical and Experimental Optometry.2021; 104(3): 396.     CrossRef
Anterior Segment Optical Coherence Tomography Angiography Assessment of Corneal Vascularisation After Combined Fine-Needle Diathermy with Subconjunctival Ranibizumab: A Pilot Study
Valencia Hui Xian Foo, Mengyuan Ke, Chelsea Qiu Lin Tan, Leopold Schmetterer, Jodhbir S. Mehta, Marcus Ang
Advances in Therapy.2021; 38(8): 4333.     CrossRef
Corneal Allografts: Factors for and against Acceptance
Justyna Sakowska, Paulina Glasner, Maciej Zieliński, Piotr Trzonkowski, Leopold Glasner, Chiara Posarelli
Journal of Immunology Research.2021; 2021: 1.     CrossRef
Therapeutic Strategies for Corneal Wound Angiogenesis
Sumana R. Chintalapudi
Current Pathobiology Reports.2020; 8(1): 15.     CrossRef
Intrastromal bevacizumab in the management of corneal neovascularization: a retrospective review
Archana A. Gupta, Danny A. Mammo, Michael A. Page
Graefe's Archive for Clinical and Experimental Ophthalmology.2020; 258(1): 167.     CrossRef
Exploring the Immunological Mechanisms Underlying the Anti-vascular Endothelial Growth Factor Activity in Tumors
Rodrigo Barbosa de Aguiar, Jane Zveiter de Moraes
Frontiers in Immunology.2019;[Epub]     CrossRef
Current and emerging therapies for corneal neovascularization
Danial Roshandel, Medi Eslani, Alireza Baradaran-Rafii, Albert Y. Cheung, Khaliq Kurji, Sayena Jabbehdari, Alejandra Maiz, Setareh Jalali, Ali R. Djalilian, Edward J. Holland
The Ocular Surface.2018; 16(4): 398.     CrossRef
Therapeutic Potential of Ranibizumab in Corneal Neovascularization
Marianne L. Shahsuvaryan
Trends in Pharmacological Sciences.2017; 38(8): 667.     CrossRef
Management of high-risk corneal transplantation
Antonio Di Zazzo, Ahmad Kheirkhah, Tulio B. Abud, Sunali Goyal, Reza Dana
Survey of Ophthalmology.2017; 62(6): 816.     CrossRef
Recent drug therapies for corneal neovascularization
Xinyao Liu, Shurong Wang, Xuanzhong Wang, Jiaming Liang, Yan Zhang
Chemical Biology & Drug Design.2017; 90(5): 653.     CrossRef
Human IgG1 antibodies suppress angiogenesis in a target-independent manner
Sasha Bogdanovich, Younghee Kim, Takeshi Mizutani, Reo Yasuma, Laura Tudisco, Valeria Cicatiello, Ana Bastos-Carvalho, Nagaraj Kerur, Yoshio Hirano, Judit Z Baffi, Valeria Tarallo, Shengjian Li, Tetsuhiro Yasuma, Parthasarathy Arpitha, Benjamin J Fowler,
Signal Transduction and Targeted Therapy.2016;[Epub]     CrossRef
Mechanisms of corneal neovascularization and modern options for its suppression
V. R. Mamikonyan, E. A. Pivin, D. A. Krakhmaleva
Vestnik oftal'mologii.2016; 132(4): 81.     CrossRef
Traitements actuels de la néovascularisation cornéenne
Y. Benayoun, F. Petellat, O. Leclerc, L. Dost, B. Dallaudière, C. Reddy, P.-Y. Robert, J.-L. Salomon
Journal Français d'Ophtalmologie.2015; 38(10): 996.     CrossRef
Ranibizumab versus Bevacizumab for Ophthalmic Diseases Related to Neovascularisation: A Meta-Analysis of Randomised Controlled Trials
Bin Wu, Haixiang Wu, Xiaoyan Liu, Houwen Lin, Jin Li, Torben Lykke Sørensen
PLoS ONE.2014; 9(7): e101253.     CrossRef